Aclaris Therapeutics (ACRS) Other financing activities (2015 - 2026)
Aclaris Therapeutics (ACRS) recorded quarterly Other financing activities of -$99000.0 in Q1 2026, down 133.0% quarter-over-quarter from $300000.0 in Q2 2021.
Aclaris Therapeutics (ACRS) Other financing activities (2015 - 2026) Analysis & Trends
Aclaris Therapeutics' Other financing activities history runs 7 years deep, the most recent figure standing at -$99000.0 for Q1 2026.
- In Q1 2026, Other financing activities changed N/A year-over-year to -$99000.0; the TTM figure through Mar 2026 stood at $75000.0 (changed N/A YoY), while the FY2024 annual figure was -$377000.0, down 4612.5% from the prior year.
- Other financing activities was -$99000.0 for Q1 2026 at Aclaris Therapeutics, down from $300000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of -$99000.0 in Q1 2026 to a low of -$99000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Aclaris Therapeutics | 580.93 Mn | 580.93 Mn | 1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -99,000.00 |
| Mar 31, 2026 | -99,000.00 |
| Jun 30, 2021 | 300,000.00 |
| Jun 30, 2021 | 300,000.00 |
| Dec 31, 2020 | -31,000.00 |
| Dec 31, 2020 | -31,000.00 |
| Sep 30, 2020 | -95,000.00 |
| Sep 30, 2020 | -95,000.00 |
| Jun 30, 2020 | -463,000.00 |
| Jun 30, 2020 | -463,000.00 |
| Mar 31, 2020 | -121,000.00 |
| Mar 31, 2020 | -121,000.00 |
| Dec 31, 2019 | 115,000.00 |
| Dec 31, 2019 | 115,000.00 |
| Sep 30, 2019 | 53,000.00 |
| Sep 30, 2019 | 53,000.00 |
| Jun 30, 2019 | -18,000.00 |
| Jun 30, 2019 | -18,000.00 |
| Mar 31, 2019 | -188,000.00 |
| Mar 31, 2019 | -188,000.00 |